In a move characteristic of the pharmaceutical industryâ€™s traditional price-structuring methods, Merck CEO Kenneth C. Frazier tantalized Americans dependent on prescriptions Friday by announcing a price reduction on life-saving drugs, setting the new prices at the point where they are just out of reach of the average citizen.